Roche Holding Ltd

VTX:ROG ISIN:CH0012032048

Roche Holding Ltd Roche Holding Ltd (VTX:ROG) (OTCMKTS:RHHBY) is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare - a strategy that aims to fit the right treatment to each patient in the best way possible.

Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2016 employed more than 94,000 people worldwide. In 2016, Roche invested CHF 9.9 billion in R&D and posted sales of CHF 50.6 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit



Lifespot Health Ltd (ASX:LSH) Enters New Market Segment of Coagulation Home Monitoring

🕔2/3/2017 2:39:21 PM 5561

Lifespot Health Ltd (ASX:LSH) is pleased to announce that its 100% owned subsidiary, BodyTel GmbH and Roche Diagnostics Deutschland GmbH, have signed an agreement to integrate Roche's newly developed Bluetooth enabled PT/INR device 'CoaguChek(R) INRange' into BodyTel's telemedical platform.

Read Full Article


  • This Page Viewed: (Last 7 Days: 17) (Last 30 Days: 42) (Since Published: 6009) 

Company Data

  • +41-61-688-8880 
  • Principal Sector
  • Biotech 
  • Principal Industry
  • Pharmaceutical 
  • Homepage
  • E:

Social Media